Cargando…

Progesterone receptors – animal models and cell signalling in breast cancer: Implications for breast cancer of inclusion of progestins in hormone replacement therapies

Progestins are included in menopausal hormone replacement therapy to counteract the increased risk for endometrial cancer associated with estrogen replacement therapy. Studies of hormone replacement therapy and breast cancer risk and of changes in mammographic density according to different regimens...

Descripción completa

Detalles Bibliográficos
Autor principal: Schairer, Catherine
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137941/
https://www.ncbi.nlm.nih.gov/pubmed/12473171